Skip to content
Nonprofiteer
← CURESHANK

Form 990 for tax year 2023

Filed by CURESHANK.

Totals

Total revenue
$464,972
Total expenses
$287,968
Contributions and grants received
$464,968
Grants paid
$50,633
Program service revenue
$0
Investment income
$4
Other revenue
$0
Total assets, end of year
$1,042,385
Total liabilities, end of year
$362
Net assets or fund balances, end of year
$1,042,023
Program services expenses (Part IX)
$225,181
Management and general expenses
$35,515
Fundraising expenses
$27,272
Program service expenses (Part III)
$225,181

Program services were 78.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $464,968

  • 3 · Investment income

    total $4 · excluded $4

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $45,000 · program services $45,000

  • 3 · Grants to foreign organizations and individuals

    total $5,633 · program services $5,633

  • 11a · Fees: management

    total $130,855 · program services $130,855

  • 11b · Fees: legal

    total $10,938 · program services $10,938

  • 11c · Fees: accounting

    total $5,801 · management and general $5,801

  • 12 · Advertising and promotion

    total $56,075 · program services $21,969 · management and general $19,282 · fundraising $14,824

  • 13 · Office expenses

    total $525 · management and general $525

  • 19 · Conferences, conventions and meetings

    total $15,128 · program services $9,858 · management and general $5,270

  • 23 · Insurance

    total $1,291 · management and general $1,291

  • 24a · Other expenses: BANK SERVICE CHARGES

    total $12,646 · management and general $198 · fundraising $12,448

  • 24b · Other expenses: SUBSCRIPTIONS

    total $3,148 · management and general $3,148

  • 24c · Other expenses: MEMBERSHIP FEES

    total $928 · program services $928

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $853,047 · end of year $1,038,385

  • 2 · Savings and temporary cash investments

    beginning of year $1,001

  • 9 · Prepaid expenses and deferred charges

    end of year $4,000

  • 17 · Accounts payable and accrued expenses

    end of year $362

  • 27 · Net assets without donor restrictions

    beginning of year $854,048 · end of year $1,042,023

Mission and programs · 2023

Mission

TO ACCELERATE THE DEVELOPMENT OF TREATMENTS FOR PHELAN-MCDERMID SYNDROME AND SHANK-RELATED DISORDERS. OUR APPROACH IS TO IDENTIFY AND FUND PROJECTS THAT OVERCOME CRITICAL BARRIERS TO SUCCESSFUL DRUG DEVELOPMENT AND TO COORDINATE SCIENTIFIC EFFORTS TO IMPROVE EFFICIENCY AND SPEED IN THE FIELD.

Activities or mission (Part I)

TO ACCELERATE THE DEVELOPMENT OF TREATMENTS FOR PHELAN-MCDERMID SYNDROME AND SHANK-RELATED DISORDERS.

  • CURESHANK WILL BRING THE SCIENTIFIC COMMUNITY TOGETHER BY ORGANIZING SCIENTIFIC SYMPOSIA AND OTHER MEETINGS. WITH OUR SCIENTIFIC STAKEHOLDERS, WE WILL DEVELOP A RESEARCH ROADMAP TO A CURE FOR SHANK-RELATED DISORDERS. WE WILL ALSO SERVE AS AN HONEST BROKER TO ENABLE COLLABORATION AMONG SHANK RESEARCHERS AND COORDINATION OF THEIR PROJECTS TO IMPROVE THE SPEED AND EFFICIENCY OF RESEARCH.

    Expenses $160,855 · Grants $30,000

  • CURESHANK WILL FUND TARGETED RESEARCH STUDIES, INCLUDING SCIENTIFIC PROJECTS THAT ELUCIDATE THE UNDERLYING DISEASE MECHANISMS, THAT IDENTIFY AND VALIDATE TARGETS FOR DRUG DEVELOPMENT, AND THAT DE-RISK PROMISING DRUG TARGETS. CURESHANK WILL ALSO FUND CERTAIN PROMISING CLINICAL TRIALS READINESS INITIATIVES. THESE ACTIVITIES ARE NEEDED TO INCREASE THE NUMBER OF DRUG TARGETS MOVING FROM ACADEMIC RESEARCH LABS INTO SUCCESSFUL INDUSTRY-SPONSORED CLINICAL TRIALS.

    Expenses $63,398 · Grants $20,633

  • CURESHANK WILL ADVOCATE FOR INCREASED FUNDING OF SHANK RESEARCH BY OTHER STAKEHOLDERS AND STRATEGIZE WITH RESEARCHERS ON INITIATIVES, SUCH AS SEED GRANTS, THAT COULD HELP ATTRACT RESEARCH INVESTMENT BY OTHER FUNDERS.

    Expenses $928

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Geraldine Bliss

    PRESIDENT

    Total calculated
    $0
    Hours/week
    50

  • Paulina Rychenkova

    SECRETARY

    Total calculated
    $0
    Hours/week
    5

  • Abby Lievense

    TREASURER

    Total calculated
    $0
    Hours/week
    15

  • Talya Emery Silva

    VICE PRESIDENT

    Total calculated
    $0
    Hours/week
    35

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

Provenance

Return type
form_990
Tax year
2023
Filed
10 November 2024
IRS schema version
2023v5.1
Source object
202403209349308725

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.